Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

NCT04953325 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Inactivated COVID-19 Vaccine
BIOLOGICAL: 23-valent pneumococcal polysaccharide vaccine
BIOLOGICAL: Inactivated Hepatitis A Vaccine

Sponsor

Sinovac Research and Development Co., Ltd.